Rare diseases
Investigational molecules
Locations
Back to Hungary346 clinical trials in Pecs, Hungary across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on the Effects of Atuliflapon in Adults with Moderate to Severe Uncontrolled Asthma
HungaryStudy of anifrolumab effectiveness compared to placebo in adults aged 18-70 with systemic sclerosis
HungaryStudy on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke
HungaryStudy on the Effect of Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease Not Adequately Managed by Current Lipid-Lowering Treatments
HungaryStudy of Pembrolizumab and Chemotherapy for Patients with HR+/HER2- Advanced Breast Cancer
HungaryStudy on the Safety of CHF5993 Inhaler with HFA-152a vs. HFA-134a in Patients with Moderate to Severe Asthma
HungaryStudy on the Effectiveness and Safety of JNJ-77242113 for Treating Moderate to Severe Plaque Psoriasis in Adults
HungaryStudy of Pembrolizumab and BCG for Patients with High-Risk Non-Muscle Invasive Bladder Cancer
HungaryStudy on the Effectiveness and Safety of Deucravacitinib for Patients with Active Systemic Lupus Erythematosus (SLE)
HungaryStudy on Benralizumab for Patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) with Frequent Exacerbations
HungaryStudy on the Effects of Filgotinib for Adults with Active Axial Spondyloarthritis
HungaryStudy on the Effectiveness and Safety of PB016 and Vedolizumab for Patients with Moderately to Severely Active Ulcerative Colitis
HungaryThe busiest research cities in the country
What the registry says about research in the country
Clinical research focusing on innovative treatments for chronic rhinosinusitis and asthma, with studies evaluating new therapeutic approaches for both conditions with and without nasal polyps.
Multiple trials investigating novel medications to improve respiratory symptoms and patient quality of life.
Groundbreaking studies in heart failure prevention and cardiomyopathy, exploring new therapeutic options for various cardiovascular conditions.
Advanced research aimed at reducing cardiovascular events and improving patient outcomes.
Innovative research into treatments for systemic sclerosis and Sjögren's syndrome, focusing on novel therapeutic approaches for these challenging conditions.
Studies evaluating new biological treatments to address various autoimmune conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
